Oragenics, Inc.
OGEN
$0.86
$0.000.43%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.07M | -2.27M | -2.22M | -3.35M | -2.46M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 0.00 | 578.60K | 192.90K | -- | -- |
| Total Other Non-Cash Items | 6.00K | 6.60K | -68.80K | 57.70K | 330.80K |
| Change in Net Operating Assets | 76.00K | 372.50K | -19.20K | 1.27M | 161.80K |
| Cash from Operations | -2.98M | -1.31M | -2.11M | -2.02M | -1.97M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 394.80K | 0.00 | 2.23M | -- | -- |
| Total Debt Repaid | -3.00M | -133.00K | -195.60K | -262.80K | -117.60K |
| Issuance of Common Stock | 0.00 | 0.00 | 2.64M | 2.00K | 3.88M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 15.02M | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 12.41M | -133.00K | 4.67M | -260.90K | 3.77M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.43M | -1.45M | 2.56M | -2.28M | 1.80M |